Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1349 of 5804
-
New antibody takes aim at Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety and efficacy of CTIM-76 (study drug), a CLDN6-directed T cell-engaging bispecific antibody , in participants with platinum-refractory/resistant ovarian cancer (PRROC) and other advanced …
Phase: PHASE1 • Sponsor: Context Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug 611 shows promise for kids with severe eczema
Disease control CompletedThe primary objective of the study was to evaluate the safety and pharmacokinetic of 611 in Chinese children and adolescents with moderate to severe atopic dermatitis.
Phase: PHASE1, PHASE2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New study explores best guselkumab dose for psoriasis in chinese patients
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, tolerability and drug survival of guselkumab in high-dose and extended-interval versus standard-dose in Chinese participants with moderate to severe plaque psoriasis.
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Eye injection could spot hidden brain bleeding risk
Diagnosis Recruiting nowThe purpose of this study is to assess safety, tolerability, plasma pharmacokinetics and biologic activity of a single intravenous dose of AMDX-2011P in participants with cerebral amyloid angiopathy (CAA).
Phase: PHASE2 • Sponsor: Amydis Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
Vitamin e derivative tested to halt pancreatic cyst growth
Prevention OngoingThis is a randomized, double-blind, placebo-controlled trial, investigating whether treatment with δ-tocotrienol (a.k.a. Delta-tocotrienol, abbreviated as DT3) will prevent the progression of Intraductal Papillary Mucinous Neoplasm (IPMN) of the pancreas.
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
New antibiotic pill could heal Flesh-Eating ulcers in weeks
Disease control Recruiting nowThe goal of this interventional clinical trial is to demonstrate the complete BU lesion healing rate by 52 weeks after treatment initiation, without relapse and/or curative intent excision surgery, after 10-28 days of telacebec (T) treatment. Males and females age 18 and older wi…
Phase: PHASE2 • Sponsor: Barwon Health • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could an Anti-Inflammatory pill help control diabetes?
Disease control Recruiting nowThe aim of the study is to determine whether NLRP3 inhibition with dapansutrile represents a new pharmacological option for diabetes management with potential as an anti-inflammatory agent to also address micro- and macro-vascular risk and complications from diabetes.
Phase: PHASE2 • Sponsor: Marc Donath • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New trial aims to stop deadly bleeding after birth
Disease control Recruiting nowThe goal of this trial is to determine if postpartum blood loss can be reduced by replenishing coagulation factor XIII (FXIII) at an early stage of postpartum hemorrhage (PPH). Summary of current body of evidence: * Morbidity and mortality due to PPH is rising. * Current guidel…
Phase: PHASE4 • Sponsor: Christian Haslinger • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can tailored brain training tame ADHD symptoms?
Symptom relief Recruiting nowThe first aim of this clinical trial is to test the feasibility and signal validity of a new approach to neurofeedback training (NF) using intensive EEG-based theta-beta NF for children with ADHD in the context of NF camps during school holidays. The second aim is to compare the …
Phase: NA • Sponsor: Bielefeld University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Magic mushroom compound targets Depression's blahs in small trial
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy of psilocybin on the symptom of anhedonia in individuals with treatment-resistant major depressive disorder.
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New hope for kids with joint pain: risankizumab trial launches
Disease control Recruiting nowPsoriatic arthritis (PsA) is a type of arthritis that happens when the body's immune system attacks healthy cells and tissues causing joint pain, stiffness, and swelling. Symptoms can get worse and go away for periods of time. PsA that begins before a patient's 16th birthday is c…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Virtual therapy aims to help Tube-Fed children with tracheostomies eat on their own
Disease control Recruiting nowThe overall objective of this proposal is to test an interdisciplinary intervention to support the transition to oral feeding for children with feeding tubes and tracheostomies. The investigators' model which combines in-home clinical assessments with virtual therapies may maximi…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug combo aims to shrink bile duct tumors before surgery
Disease control Recruiting nowThe purpose of this study is to determine the safety of peri-operative gemcitabine, cisplatin, and pembrolizumab in patients with BTC, as well as whether the combination of gemcitabine, cisplatin, and pembrolizumab (gem/cis/pembro) is feasible and lead to pathologic responses.
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can a classroom curriculum stop child sex trafficking? large trial launches
Prevention Recruiting nowThe overall goal of the five-year project is to conduct both a process and rigorous outcome evaluation of The Set Me Free Project (SMFP)'s READY to Stand (RTS)© curriculum with an eye toward widespread dissemination to other U.S. communities, if deemed effective. Broadly, the inv…
Phase: NA • Sponsor: University of Michigan • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
New tools aim to boost colonoscopy rates and prevent cancer
Prevention ENROLLING_BY_INVITATIONComplete and timely colonoscopy after an abnormal stool-based colorectal cancer screening test results in early detection, cancer prevention, and reduction in mortality, but follow-up in safety-net health systems occurs in less than 50% at 6 months. The proposal will implement mu…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control CompletedThis is a first-in-human, Phase 1a/1b study to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of BGB-C354 alone and in combination with tislelizumab in participants with advanced solid tumors. Study details include: * The study will be c…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Heart-Brain link: major study seeks hidden causes of learning delays in children with heart defects
Knowledge-focused Recruiting nowThe leading cause of birth defects, Congenital Heart Defects (CHD) affect 12 million people worldwide and 41,000 newborns/year in Europe. It's a major cause of life-long morbidity and mortality, and a crucial public health issue. More than 50% of childs born with critical CHD wil…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
New membrane could speed healing of eye infections
Disease control CompletedThis study aims to evaluate the effectiveness of a specialized amniotic membrane preparation as an adjuvant therapy for patients with moderate-to-severe infected corneal ulcers. The specialized membrane contains a combination of Riboflavin and Moxifloxacin, which is applied duri…
Phase: PHASE2 • Sponsor: Gadjah Mada University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Experimental combo aims to tackle Hard-to-Treat prostate cancer
Disease control Recruiting nowCarrying out clinical trials of salbutamol hydrochloride combined with immunotherapy and castration for the treatment of prostate cancer is of great significance. Firstly, it can verify the efficacy and safety of this combination in the treatment of prostate cancer, providing a s…
Phase: PHASE2 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Parkinson's patients get new hope: group therapy targets anxiety and depression
Symptom relief CompletedIn addition to increasingly severe physical symptoms, Parkinson's can cause distressing mental health issues. These include anxiety, depression, and memory and thinking problems, caused by a combination of biological and psychological factors. They can be more disabling than phys…
Phase: NA • Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC